The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

Researchers at the University of Tsukuba have reported on the structure and light energy transfer efficiency of a protein ...

Organolithium compounds, molecules containing a carbon–lithium bond, are excellent precursors for building new carbon–carbon ...

Two new catalyst systems take aim at these problems. One catalyst splits ethanol to give hydrogen at 270 °C and produces ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

Exxon Mobil Corporation’s XOM acquisition of Pioneer Natural Resources was given the final approval by the U.S. regulatory body, the Federal Trade Commission (“FTC”), on Jan. 17, 2025. In the same ...